Operating Segments (Tables)

6 Months Ended

Jun. 30, 2021

Operating Segments

Schedule of operating segments

	Three Months Ended
	June 30,
	2021		2020
Revenues
Public Health Solutions	$	214,824	$	468,009
Specialized BioTherapeutics		—		37,279
Total	$	214,824	$	505,288
Loss from Operations
Public Health Solutions	$	(231,954)	$	(50,737)
Specialized BioTherapeutics		(1,720,566)		(1,808,652)
Corporate		(1,057,125)		(954,483)
Total	$	(3,009,645)	$	(2,813,872)
Amortization and Depreciation Expense
Public Health Solutions	$	311	$	7,318
Specialized BioTherapeutics		1,862		3,167
Corporate		6,667		7,317
Total	$	8,840	$	17,802
Other Income, Net
Specialized BioTherapeutics	$	41,001		35,091
Corporate		206,834		2,018
Total	$	247,835	$	37,109
Share-Based Compensation
Public Health Solutions	$	7,189	$	8,377
Specialized BioTherapeutics		28,731		18,962
Corporate		44,701		53,664
Total	$	80,621	$	81,003

	Six Months Ended
	June 30,
	2021		2020
Revenues
Public Health Solutions	$	362,417	$	1,376,818
Specialized BioTherapeutics		—		53,024
Total	$	362,417	$	1,429,842
Loss from Operations
Public Health Solutions	$	(362,735)	$	(209,239)
Specialized BioTherapeutics		(2,832,974)		(9,166,503)
Corporate		(2,047,543)		(1,911,919)
Total	$	(5,243,252)	$	(11,287,661)
Amortization and Depreciation Expense
Public Health Solutions	$	627	$	14,621
Specialized BioTherapeutics		3,761		6,237
Corporate		13,351		14,590
Total	$	17,739	$	35,448
Other Income/(Loss), Net
Specialized BioTherapeutics	$	125,635	$	68,706
Corporate		(6,671)		23,965
Total	$	118,964	$	92,671
Share-Based Compensation
Public Health Solutions	$	13,484	$	17,842
Specialized BioTherapeutics		58,310		44,251
Corporate		103,632		82,601
Total	$	175,426	$	144,694

	As of		As of
	June 30,		December 31,
	2021		2020
Identifiable Assets
Public Health Solutions	$	123,427	$	176,447
Specialized BioTherapeutics		34,272		147,784
Corporate		29,452,590		19,567,004
Total	$	29,610,289	$	19,891,235